Finance

Lists
HYPMY:OTCMKTS
HYPERA S A SPONSORED Brazil ADR
5,30 USD
0,00%
(0,00) 1D
16-окт., 15:59:56 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HYPMY...
Mkt. cap
18,59 млд
Avg. vol.
194,04 миң
Volume
8,00
52-wk high
5,77 USD
52-wk low
3,75 USD
Beta
0,58
Shares outstanding
704,01 млн
No. of employees
11 миң
Mkt. cap
18,59 млд
Avg. vol.
194,04 миң
Volume
8,00
52-wk high
5,77 USD
52-wk low
3,75 USD
Beta
0,58
Shares outstanding
704,01 млн
No. of employees
11 миң
News stories
From web sources and news partners
Profile
Hypera Pharma is a Brazilian multinational pharmaceutical company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
About HYPERA S A SPONSORED Brazil ADR
CEO-
Employees10,6 миң
Founded2001
HeadquartersItaim Bibi, Сан-Па́улу штаты, Бразилия
SectorPharmaceutical industry
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,23 млд
2,24 млд
2,02 млд
2,34 млд
Cost of goods sold
865,21 млн
858,94 млн
807,22 млн
892,99 млн
Cost of revenue
865,21 млн
858,94 млн
807,22 млн
892,99 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
687,46 млн
728,46 млн
703,28 млн
780,69 млн
Operating expense
688,45 млн
728,74 млн
701,06 млн
773,84 млн
Total operating expenses
1,55 млд
1,59 млд
1,51 млд
1,67 млд
Operating income
673,59 млн
649,38 млн
509,50 млн
669,87 млн
Other non operating income
-14,67 млн
-27,28 млн
-8,73 млн
-30,17 млн
EBT including unusual items
448,11 млн
439,21 млн
276,14 млн
492,29 млн
EBT excluding unusual items
452,42 млн
438,30 млн
279,75 млн
488,66 млн
Income tax expense
-5,77 млн
-10,46 млн
-69,54 млн
2,28 млн
Effective tax rate
-1,29%
-2,38%
-25,18%
0,46%
Other operating expenses
987,00 миң
283,00 миң
-2,21 млн
-6,84 млн
Net income
457,64 млн
450,99 млн
347,38 млн
490,24 млн
Net profit margin
20,55%
20,16%
17,22%
20,98%
Earnings per share
0,72
0,71
0,55
0,70
Interest and investment income
69,23 млн
68,87 млн
64,66 млн
63,02 млн
Interest expense
-283,65 млн
-268,84 млн
-282,34 млн
-209,57 млн
Net interest expenses
-214,42 млн
-199,97 млн
-217,68 млн
-146,55 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
728,99 млн
702,34 млн
562,68 млн
755,79 млн
Gain or loss from assets sale
-11,00 миң
-253,00 миң
-3,20 млн
-698,00 миң
AI content may include mistakes. Learn more
Google колдонмолору